Update on Regulation of Homeopathic Products: It's the FTC's Turn

– New Hope 360

On April 3, I reported in the IdeaXchange that the FDA was re-evaluating the way it regulates homeopathic drug products. Now, it is the Federal Trade Commission's turn.

The FTC announced that on September 21 it will host a public workshop in Washington D.C. to examine advertising for over-the-counter homeopathic products.

Like dietary supplements and functional foods, the FDA and FTC share jurisdiction over OTC homeopathic drug products.  FDA has primary jurisdiction over claims made on the labels and labeling of the products, while FTC has primary jurisdiction over claims made in advertising for such products.

Read the article here



pursuant to New York DR 2-101(f)

© 2022 Manatt, Phelps & Phillips, LLP.

All rights reserved